American Urological Association (AUA) Primary Care Update in Urology Webcast
| Title: | American Urological Association (AUA) Primary Care Update in Urology Webcast |
| Topic: | Urology |
| Relevant Terms: | Benign Prostatic Hyperplasia (BPH), Cardiometabolic Syndrome, ED/Hypogonadism, Geriatrics, Hypertension, Lower Urinary Tract Symptoms (LUTS), Overactive Bladder (OAB), Pediatric Urology, Prostate Cancer And Kidney |
| Primary Audience: | Primary care providers (MDs/ DOs/ NPs/ PAs) |
| Launch Date: | 03-Jul-12 |
| Credits: | 3 AMA PRA Category 1 Credits™ 3 AAFP CME Credits |
| Expiration Date: | 05-Jul-13 |
Learning Objectives
After completing this activity, the participant will demonstrate the ability to:
- Discuss screening methods, causes and treatment options of erectile dysfunction, hypogonadism and metabolic syndrome
- Outline specific urologic conditions in the elderly population
- Describe screening methods, identification and treatment options of Lower Urinary Tract Symptoms (LUTS), Overactive Bladder (OAB) and Benign Prostatic Hyperplasia (BPH)
- Discuss the surgically correctable causes of hypertension
- Outline basic pediatric urologic problems and their management including urinary tract infections, enuresis, undescended testis and torsion of the testis
- Explain screening, detection, treatment and impact of prostate cancer
- Review risk factors, identification, and how to manage kidney stone disease
Faculty

Method of Participation
1. Read the CME information.
2. Click "Enter the Activity" link located at the bottom of the page.
3. Login with your Epocrates or CME Companion user ID and password. If you do not have an Epocrates or CME Companion account, you will be prompted to create one. It is recommended that you use your email address for your username and a password when creating your account.
4. To claim credit, complete the pre-test, view the webcast, pass the posttest with 80% accuracy and submit the evaluation.
CME Information
Program Description1. Read the CME information.
2. Click "Enter the Activity" link located at the bottom of the page.
3. Login with your Epocrates or CME Companion user ID and password. If you do not have an Epocrates or CME Companion account, you will be prompted to create one. It is recommended that you use your email address for your username and a password when creating your account.
4. To claim credit, complete the pre-test, view the webcast, pass the posttest with 80% accuracy and submit the evaluation.
CME Information
The purpose of this program is to aid primary care providers in screening, detection and referral of common urological health issues. Topics to be addressed include ED/Hypogonadism and Cardiometabolic Syndrome, Geriatrics in Urology, Lower Urinary Tract Symptoms (LUTS)/Overactive Bladder (OAB)/Benign Prostatic Hyperplasia (BPH), Hypertension: Surgically Correctable Etiologies, Pediatric Urology, Prostate Cancer and Kidney Stone Disease.
Accreditation
The American Urological Association Education & Research, Inc. (AUAER) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
American Urological Association
The American Urological Association Education & Research, Inc. designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Urological Association
The American Urological Association Education & Research, Inc. designates this enduring material for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Family Physicians
This Enduring Material activity, Primary Care Update in Urology, has been reviewed and is acceptable for up to 3 Prescribed credit(s) by the American Academy of Family Physicians.
AAFP certification begins June 29, 2012. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
AAFP certification begins June 29, 2012. Term of approval is for one year from this date with the option of yearly renewal. Physicians should claim only the credit commensurate with the extent
of their participation in the activity.
The AUAER takes responsibility for the content, quality, and scientific integrity of this CME activity.
Medium or Combination of Media Used
Online
Method of Participation in the Learning Process
Participants must complete the pre-test, view the webcast, pass the posttest with 80% accuracy and submit the evaluation to claim credit and print a certificate for this activity.
Navigation Instructions
A segmented, navigational bar is located at the top of the screen for participants to monitor their progress during the activity. Each segment represents a page of the activity. As you complete each page of the activity, a pointer moves to the right. The activity begins with a pre-test and review (pages 1-2). This is followed by the activity content/presentations (pages 3-10), activity feedback and references (page 11), posttest (pages 12-13), pre-posttest results (page 14), evaluation form (page 15) and claim credit form (page16).
A segmented, navigational bar is located at the top of the screen for participants to monitor their progress during the activity. Each segment represents a page of the activity. As you complete each page of the activity, a pointer moves to the right. The activity begins with a pre-test and review (pages 1-2). This is followed by the activity content/presentations (pages 3-10), activity feedback and references (page 11), posttest (pages 12-13), pre-posttest results (page 14), evaluation form (page 15) and claim credit form (page16).
Hardware/Software Requirements
- PC-compatible computer running Windows XP
- Macintosh computer running OS X 10.1 or later
- Linux computer capable of running Mozilla Firefox 3.0 or later
Processor speed of 800 MHz (1GHz preferred). A minimum of 128 MB of RAM or more preferred). A modem speed of at least 56k (broadband preferred). Internet browser should be one of the following: Internet Explorer 8.0 or later, Firefox 3.0 or later, Chrome 4.0 or later, or Safari 4.0 or later. Software requirement: Adobe Acrobat Reader 9 or newer.
Estimated Time to Complete the Educational Activity
3 hours
3 hours
Release Date
July 5, 2012
July 5, 2012
Expiration Date
July 3, 2013
AUAER Disclosure Policy
As a provider accredited by the ACCME, the AUAER must ensure balance, independence, objectivity and scientific rigor in all its activities.
As a provider accredited by the ACCME, the AUAER must ensure balance, independence, objectivity and scientific rigor in all its activities.
All persons in a position to control the content of an educational activity (i.e., activity planners and presenters) provided by the AUAER are required to disclose to the provider any relevant financial relationships they have with any commercial interest. The AUAER must determine if an individual's commercial relationships may influence the educational content with regard to exposition or conclusion, and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from serving as planners or presenters, but rather to provide the audience with information on which they can make informed judgments about the material presented.
Faculty Disclosures
Sargent, Eric R.: Nothing to Disclose
Winfield, Howard: North Central Section of the AUA, Leadership Position – Financial: No
Griebling, Tomas: Pfizer: Health Publishing, Scientific Study/Trial; Medtronic: Health Publishing, Scientific Study/Trial. Financial: Yes
Matlaga, Brian R.: Boston Scientific: Consultant/Advisor, Financial: Yes
Nehra, Ajay: Nothing to Disclose
Rosenberg, Matthew: Astellas: Consultant or Advisor, Meeting Participant/Lecturer Allergan:
Consultant/Advisor; Forest: Other, Pfizer: Consultant or Advisor/Other Purdue: Consultant or Advisor/Other; Endo:Consultant or Advisor Financial All: Yes
Consultant/Advisor; Forest: Other, Pfizer: Consultant or Advisor/Other Purdue: Consultant or Advisor/Other; Endo:Consultant or Advisor Financial All: Yes
Thom, Matthew: Nothing to Disclose
Planners' Disclosures
Elspeth McDougall, MD, FRCSC, MHPE
Associate Dean of Continuing & Simulation Medical Education
Director, Minimally Invasive Surgery Education Center
Chair, AUA Office of Education
University of California – Irvine
Irvine, CA
Disclosure: Ethicon Endo-Surgery: Other: Equipment Support, Other: Equipment Support ; Karl Storz Endoscopy America: Other: Equipment Support
Amling, Christopher Lee: Janssen: Meeting Participant or Lecturer
Disclosure: Ethicon Endo-Surgery: Other: Equipment Support, Other: Equipment Support ; Karl Storz Endoscopy America: Other: Equipment Support
Amling, Christopher Lee: Janssen: Meeting Participant or Lecturer
Badlani, Gopal: Olympus: Scientific Study or Trial; Allergan: Scientific Study or Trial; Lithotripsy Group: Piedmont Stone & Physcian Discovery: Investment Interest
Carroll, Peter Robert: NIH: Scientific Study or Trial ; Department of Defense: Scientific Study or Trial ; Myriad Genetics: Scientific Study or Trial; Genomic Health: Scientific Study or Trial; Abbott Pharmaceuticals: Scientific Study or Trial; AUA Update: Leadership Position; Astra Zeneca: Meeting Participant or Lecturer
Cohen, Marc S.: Nothing to disclose
Cohen, Marc S.: Nothing to disclose
Flanigan, Robert C.: NIDDK (NIH): Consultant or Advisor; WJ Weiser: Employee; National Cancer Institute: Scientific Study or Trial
Fulgham, Pat Fox: Urology Clinics of North Texas: Investment Interest
Gilbert, Bruce R.: Bayer Healthcare Pharmaceuticals Inc.: Scientific Study or Trial; Auxilium: Scientific Study or Trial; Clarus Pharmaceutcals: Scientific Study or Trial
Hernandez, Christina: Nothing to disclose
Jarrard, David F.: Johnson and Johnson: Consultant or Advisor
Joseph, David B.: Tengion: Scientific Study or Trial; Centers for Disease Control and Prevention: Scientific Study or Trial
Kogan, Barry A.: Watson Pharmaceuticals: Consultant or Advisor; United Urology: Investment Interest
Lee, Benjamin R.: Nothing to disclose
Mathe, Mary: Nothing to disclose
McDougall, Elspeth Marguerita: Ethicon Endo-Surgery: Other: Equipment support , Other: Equipment Support ; Karl Storz Endoscopy America: Other: Equipment Support
Mian, Badar Munir: Nothing to disclose
Mourtzinos, Arthur P.: Johnson & Johnson: Other: Proctor, pelvic floor cadaver lab instructor; Allergan: Other: Lecturer ; Coloplast: Other: Proctor, pelvic floor cadaver lab instructor ; American Medical Systems: Other: Proctor, pelvic floor cadaver lab instructor ; Astellas: Other: Lecturer
Parsons, J. Kellogg: AMS: Meeting Participant or Lecturer
Sandhu, Jaspreet Singh: American Medical Systems: Consultant or Advisor
Steers, William Donald: National Institutes of Health: Consultant or Advisor, Meeting Participant or Lecturer; Food and Drug Administration: Consultant or Advisor; Allergan: Scientific Study or Trial; New England Research Institute (NERI): Consultant or Advisor, Scientific Study or Trial
Stoffel, John T.: Nothing to disclose
Stoffel, John T.: Nothing to disclose
Sundaram, Chandru P.: Nothing to disclose
Sweet, Robert Marten: Red Llama Incorporated: Leadership Position,Investment Interest,Owner, Product Development,Employee ; American Medical Systems Holding, Inc.: Meeting Participant or Lecturer,Scientific Study or Trial; Coruthers Health Consulting: Consultant or Advisor; Allergan: Scientific Study or Trial;
Medtronic: Scientific Study or Trial; Olympus: Other: International Surgical Simulation Fellowship
Wang, Zhou: Nothing to disclose
Medtronic: Scientific Study or Trial; Olympus: Other: International Surgical Simulation Fellowship
Wang, Zhou: Nothing to disclose
Wein, Alan J.: ENDO Pharmaceuticals: Consultant or Advisor,Meeting Participant or Lecturer; Allergan: Consultant or Advisor,Meeting Participant or Lecturer; Medtronic: Consultant or Advisor,Meeting Participant or Lecturer; Ferring Pharmaceuticals: Consultant or Advisor, Meeting Participant or Lecturer; Pfizer: Consultant or
Advisor, Meeting Participant or Lecturer; Astellas: Consultant or Advisor, Meeting Participant or Lecturer
Advisor, Meeting Participant or Lecturer; Astellas: Consultant or Advisor, Meeting Participant or Lecturer
Resolution of Identified Conflict of Interest
All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:
- Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup.
- Limit content to evidence with no recommendations
- Introduction of a debate format with an unbiased moderator (point-counterpoint)
- Inclusion of moderated panel discussion
- Publication of a parallel or rebuttal article for an article that is felt to be biased
- Limit equipment representatives to providing logistics and operation support only in procedural
demonstrations - Divestiture of the relationship by faculty
Commercial Support Acknowledgement
Support for this activity is provided by educational grants from Astellas Scientific and Medical Affairs, Inc., Cook Medical, Endo Pharmaceuticals, HealthTronics and Lilly USA, LLC.
Off-label or Unapproved Use of Drugs or Devices
It is the policy of the AUAER to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
Disclaimer
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUAER.
The opinions and recommendations expressed by faculty, authors, and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUAER.
Evidence Based Content
As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUAER to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
As a provider of continuing medical education accredited by the ACCME, it is the policy of the AUAER to review and certify that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
Copyright © 2012 American Urological Association Education and Research, Inc.
Privacy Policy
http://www.auanet.org/content/education-and-meetings/statements-and-policies.cfm?sub=confidentiality
http://www.auanet.org/content/education-and-meetings/statements-and-policies.cfm?sub=confidentiality
Contact
Denise Williams, MEd
Enduring Materials CoordinatorOffice of Education
American Urological Association
1000 Corporate Boulevard
Linthicum, MD 21090
P 410-689-3751
F 410-689-3904
CME@AUAnet.org








